These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31276031)
1. Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Ueta M; Sotozono C; Nishigaki H; Ohsako S; Yokoi N; Mizushima K; Naito Y; Kinoshita S BMJ Open Ophthalmol; 2019; 4(1):e000254. PubMed ID: 31276031 [TBL] [Abstract][Full Text] [Related]
2. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Ueta M; Nishigaki H; Sotozono C; Yokoi N; Mizushima K; Naito Y; Kinoshita S Sci Rep; 2020 Oct; 10(1):17239. PubMed ID: 33057072 [TBL] [Abstract][Full Text] [Related]
3. Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study. Ueta M; Sotozono C; Yamada K; Yokoi N; Inatomi T; Kinoshita S BMJ Open; 2012; 2(5):. PubMed ID: 23065448 [TBL] [Abstract][Full Text] [Related]
4. Expression of prostaglandin E Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507 [TBL] [Abstract][Full Text] [Related]
5. Ocular surface inflammation mediated by innate immunity. Ueta M; Kinoshita S Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders. Ueta M; Sotozono C; Yokoi N; Inatomi T; Kinoshita S PLoS One; 2011; 6(9):e25209. PubMed ID: 21966456 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases. Yamada K; Ueta M; Sotozono C; Yokoi N; Inatomi T; Kinoshita S Br J Ophthalmol; 2014 Aug; 98(8):1116-9. PubMed ID: 24820048 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage. Ueta M; Nishigaki H; Sotozono C; Kinoshita S BMJ Open Ophthalmol; 2017; 1(1):e000073. PubMed ID: 29354711 [TBL] [Abstract][Full Text] [Related]
10. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation. Gurumurthy S; Iyer G; Srinivasan B; Agarwal S; Angayarkanni N Br J Ophthalmol; 2018 Feb; 102(2):169-176. PubMed ID: 28689166 [TBL] [Abstract][Full Text] [Related]
12. [Conjunctival Fas-FasL expression in chronic Stevens-Johnson syndrome]. Chen S; Jiang Y; Wang Z; Li Y Zhonghua Yan Ke Za Zhi; 2014 Sep; 50(9):691-4. PubMed ID: 25533561 [TBL] [Abstract][Full Text] [Related]
13. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications. Ueta M Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications. Ueta M Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome. Moon J; Lee Y; Yoon CH; Kim MK BMC Ophthalmol; 2022 Apr; 22(1):179. PubMed ID: 35440028 [TBL] [Abstract][Full Text] [Related]
16. Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis. Williams GP; Tomlins PJ; Denniston AK; Southworth HS; Sreekantham S; Curnow SJ; Rauz S Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4578-85. PubMed ID: 23737478 [TBL] [Abstract][Full Text] [Related]
17. Conjunctival diverticuli in Stevens-Johnson syndrome. Ziaei M; Tuft S; Verity D Optom Vis Sci; 2015 Jun; 92(6):e134-7. PubMed ID: 25909242 [TBL] [Abstract][Full Text] [Related]
18. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335 [TBL] [Abstract][Full Text] [Related]
19. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome. Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084 [TBL] [Abstract][Full Text] [Related]
20. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. De Rojas MV; Dart JK; Saw VP Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]